Skip to main content
Clinical Trials/NL-OMON44602
NL-OMON44602
Completed
Not Applicable

A randomized controlled trial to evaluate the efficacy of the Spinal Modulation Axium neurostimulator therapy as a treatment for persistent inguinal pain following surgical intervention. - SMASHING

Maxima Medisch Centrum0 sites78 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
chronische liespijn
Sponsor
Maxima Medisch Centrum
Enrollment
78
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Maxima Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • Subject is at least 18 years old.
  • Subject is able and willing to comply with the follow\-up schedule and protocol.
  • Chronic inguinal pain following pfannenstiel incision or inguinal hernia repair or laparoscopic inguinal repair for at least 6 months.
  • Previously undergone neurectomy procedure as a treatment for chronic inguinal pain.
  • Minimum baseline pain rating of 6 out of 10 in the inguinal area on an 11\-point NPRS.
  • Subject is able to provide written informed consent.
  • Meets the inclusion criteria for the implantation of a neurostimulation system as set out by the Dutch Neuromodulation Society.
  • Subject has been screened by a multi\-disciplanary panel including the designated psychologist of the Máxima Medical Centre Eindhoven and deemed suitable for implantation.
  • Neuropathic Pain as described by a score of \*4 on the DN4 questionnaire

Exclusion Criteria

  • Female subject of childbearing potential is pregnant/nursing or plans to become pregnant during the course of the trial.
  • Escalating or changing pain condition within the past month as evidenced by investigator examination.
  • Subject has had injection therapy or radiofrequency treatment of a target neural structure within the past 3 months
  • Subject currently has an active implantable device including ICD, pacemaker, spinal cord stimulator or intrathecal drug pump.
  • Subject is unable to operate the device.
  • Subject currently has an active infection.
  • Subject has participated in another clinical investigation within 30 days.
  • Subject has a coagulation disorder or uses anticoagulants that, in the opinion of the investigator, precludes participation.
  • Subject has a current or ongoing condition, which will probably require MRI investigation sometime in the following 2 years
  • Subject has had a spinal surgical procedure at or between vertebral levels T10\-L2\.

Outcomes

Primary Outcomes

Not specified

Similar Trials